Divalproex Capsules and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Divalproex Capsules and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex Capsules-Insulin glulisine
- Divalproex Capsules-Insulin Glulisine (Cartridges and Pens)
- Divalproex Capsules-Insulin Glulisine (Vials)
- Divalproex Capsules-Insulin glulisine Subcutaneous
- Divalproex Capsules-Insulin human inhaled Inhalation
- Divalproex Capsules-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Divalproex Delayed Release
- Insulin glargine, recombinant Subcutaneous-Divalproex Delayed Release Tablets
- Insulin glargine, recombinant Subcutaneous-Divalproex Extended Release
- Insulin glargine, recombinant Subcutaneous-Divalproex Long-Acting Tablets
- Insulin glargine, recombinant Subcutaneous-Divalproex sodium
- Insulin glargine, recombinant Subcutaneous-Divalproex Sprinkle